Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against Nobilis Health Corp. (HLTH) and Encourages HLTH Investors to Contact the Firm
NEW YORK, Dec. 17, 2018 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. announces that a class action lawsuit has been filed in the U.S. District Court for the Southern District of Texas on behalf of all persons or entities who purchased or otherwise acquired Nobilis Health Corp. (NYSE: HLTH) securities between May 8, 2018 and November 15, 2018 (the “Class Period”). Investors have until February 12, 2019 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
The complaint alleges that throughout the class period defendants made materially false and misleading statements and failed to disclose that: (1) Nobilis’ accounts receivable was overstated; (2) Nobilis’ revenue was overstated; (3) as a result of the required adjustments, Nobilis’ quarterly report would not be timely filed; (4) Nobilis would not be in compliance with NYSE listing requirements; and (5) due to the foregoing, defendants’ positive statements about Nobilis’ business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
If you purchased Nobilis securities during the Class Period or continue to hold shares purchased before the Class Period, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Melissa Fortunato by email at email@example.com, or telephone at (212) 355-4648, or by filling out this contact form. There is no cost or obligation to you.
Bragar Eagel & Squire, P.C. is a New York-based law firm concentrating in commercial and securities litigation. For additional information concerning the Nobilis lawsuit, please go to https://bespc.com/hlth/. For additional information about Bragar Eagel & Squire, P.C. please go to www.bespc.com. Attorney advertising. Prior results do not guarantee similar outcomes.